Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026
Same author

Guidelines for the Intraprocedural Imaging for Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER): Recommendations from the American Society of Echocardiography.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Cardiopulmonary Bypass Effects on Minimum Alveolar Concentration and Other Bypass Terminology.

Anesthesia and analgesia·2026
Same author

Adapting Interventional Echocardiography to New Techniques: Echocardiographic Guidance for Transcatheter Myotomy Using Septal Scoring Along the Midline Endocardium.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Enhanced Recovery After Cardiac Surgery: Society of Cardiovascular Anesthesiologists (SCA) and American Society of Anesthesiologists (ASA) Membership Survey.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Corrigendum to '2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion': [Journal of the Society for Cardiovascular Angiography & Interventions. Volume 4, Issue 9 (2025) 103783].

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Related Experiment Video

Updated: Jul 6, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Neuroprotection during cardiac surgery.

Niamh Conlon1, Hilary P Grocott, G Burkhard Mackensen

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. niamh.conlon@duke.edu

Expert Review of Cardiovascular Therapy
|April 12, 2008
PubMed
Summary

Minimizing brain injury during cardiac surgery is crucial. While drugs show promise, evidence supports non-drug methods like ultrasound and temperature control for neuroprotection.

Area of Science:

  • Neurology
  • Cardiology
  • Surgical Innovation

Background:

  • Cardiac surgery carries a high risk of adverse cerebral outcomes, including stroke and cognitive impairment.
  • Mechanisms involve cerebral embolism, hypoperfusion, and ischemia/reperfusion injury, with incomplete understanding.
  • Extensive research targets minimizing perioperative brain injury through various strategies.

Purpose of the Study:

  • To review current pharmacological and non-pharmacological neuroprotection strategies in cardiac surgery.
  • To evaluate the evidence supporting different neuroprotective interventions.
  • To discuss future research directions for preventing brain injury during cardiac procedures.

Main Methods:

  • Review of preclinical and clinical studies on neuroprotection during cardiac surgery.

More Related Videos

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation
07:18

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation

Published on: April 14, 2023

Related Experiment Videos

Last Updated: Jul 6, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation
07:18

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation

Published on: April 14, 2023

  • Analysis of evidence for pharmacological agents and non-pharmacological techniques.
  • Discussion of ongoing research and future trial requirements.

    • Main Results:

    • No pharmacological agents are currently recommended for routine neuroprotection due to insufficient clinical trial evidence.
    • Non-pharmacological strategies, including transesophageal echocardiography and epiaortic ultrasound for aortic assessment, and optimal temperature management, are evidence-based.
    • Further large-scale trials are needed for optimal management of pH, glycemic control, blood pressure, and hematocrit during cardiopulmonary bypass.

    Conclusions:

    • Current evidence supports specific non-pharmacological interventions for neuroprotection during cardiac surgery.
    • Pharmacological neuroprotection lacks sufficient clinical validation for routine use.
    • Future research should focus on large randomized trials to optimize management strategies during cardiopulmonary bypass.